FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2046660201> ?p ?o ?g. }

• W2046660201 endingPage "237" @default.
• W2046660201 startingPage "227" @default.
• W2046660201 abstract "Currently, an accepted post-surgical treatment of patients with thyroid carcinoma is administration of an ablative dose of I. This treatment is well established based on extensive experience and modeling. However, for patients with renal disease, reduced iodine removal rates result in controversial thyroid doses and potentially excessive red bone marrow doses. There are differences of opinion regarding I dose recommendations ranging from a reduction in dose to an increase in dose compared with conventional amounts. Determination of suitable doses must take into account varying dialysis protocols and absorbed dose considerations to the thyroid and sensitive tissues such as red bone marrow. The specific aim of this study was to develop a simple yet comprehensive compartmental model for I kinetics in patients with thyroid carcinoma and end stage renal disease, which accounts for dialysis and provides absorbed dose estimates for the thyroid as well as the red bone marrow. STELLA, a compartmental modeling software program, was used to develop a kinetic model that includes the blood pool, thyroid, gastrointestinal tract, kidneys, bladder, and a conventional dialysis machine. Benchmarking was performed to demonstrate the validity of the model with data obtained from ICRP 30 and MIRD Dose Estimate Report No. 5. Iodine kinetics were simulated for normal patients, thyroid cancer patients, and patients with thyroid cancer and renal failure undergoing two standard types of dialysis, hemodialysis and continuous ambulatory peritoneal dialysis (CAPD). Results in this work show that thyroid doses to patients with thyroid cancer and renal failure on hemodialysis or CAPD are slightly higher than doses to patients with thyroid cancer and normal renal function. These results further indicate that red bone marrow doses to patients with thyroid cancer and renal failure on dialysis can be significantly higher than red bone marrow doses to patients with thyroid cancer and normal renal function, and thus these patients could benefit from a reduction in administered activity. Thyroid doses and red bone marrow doses to patients on standard hemodialysis depend on both dialysis frequency and the time interval between administration and first dialysis. The results in this study provide guidelines on how much activity a patient on dialysis should receive based on thyroid and red bone marrow absorbed dose (Gy MBq) considerations. This study should help to clarify some of the contradictory recommendations regarding I dose for thyroid carcinoma patients with renal failure." @default.
• W2046660201 created "2016-06-24" @default.
• W2046660201 creator A5029331085 @default.
• W2046660201 creator A5035049256 @default.
• W2046660201 date "2006-09-01" @default.
• W2046660201 modified "2023-10-12" @default.
• W2046660201 title "THE EFFECTS OF DIALYSIS ON 131I KINETICS AND DOSIMETRY IN THYROID CANCER PATIENTS???A PHARMACOKINETIC MODEL" @default.
• W2046660201 cites W1501607388 @default.
• W2046660201 cites W1967750949 @default.
• W2046660201 cites W1972740891 @default.
• W2046660201 cites W1994485412 @default.
• W2046660201 cites W1995307867 @default.
• W2046660201 cites W2003249527 @default.
• W2046660201 cites W2011823284 @default.
• W2046660201 cites W2014659175 @default.
• W2046660201 cites W2017534551 @default.
• W2046660201 cites W2021012936 @default.
• W2046660201 cites W2034935885 @default.
• W2046660201 cites W2036059885 @default.
• W2046660201 cites W2057389748 @default.
• W2046660201 cites W2064972542 @default.
• W2046660201 cites W2065447757 @default.
• W2046660201 cites W2068735665 @default.
• W2046660201 cites W2085096032 @default.
• W2046660201 cites W2094427504 @default.
• W2046660201 cites W2097510903 @default.
• W2046660201 cites W2114382510 @default.
• W2046660201 cites W2114999302 @default.
• W2046660201 cites W2147243213 @default.
• W2046660201 cites W2152591331 @default.
• W2046660201 cites W2166787623 @default.
• W2046660201 cites W2268609411 @default.
• W2046660201 cites W2320378887 @default.
• W2046660201 cites W2330119179 @default.
• W2046660201 cites W7558219 @default.
• W2046660201 doi "https://doi.org/10.1097/01.hp.0000214660.13440.64" @default.
• W2046660201 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16891898" @default.
• W2046660201 hasPublicationYear "2006" @default.
• W2046660201 type Work @default.
• W2046660201 sameAs 2046660201 @default.
• W2046660201 citedByCount "11" @default.
• W2046660201 countsByYear W20466602012013 @default.
• W2046660201 countsByYear W20466602012015 @default.
• W2046660201 countsByYear W20466602012016 @default.
• W2046660201 countsByYear W20466602012018 @default.
• W2046660201 countsByYear W20466602012021 @default.
• W2046660201 crossrefType "journal-article" @default.
• W2046660201 hasAuthorship W2046660201A5029331085 @default.
• W2046660201 hasAuthorship W2046660201A5035049256 @default.
• W2046660201 hasConcept C126322002 @default.
• W2046660201 hasConcept C126894567 @default.
• W2046660201 hasConcept C141071460 @default.
• W2046660201 hasConcept C2778063415 @default.
• W2046660201 hasConcept C2779761222 @default.
• W2046660201 hasConcept C2779978075 @default.
• W2046660201 hasConcept C2989005 @default.
• W2046660201 hasConcept C2993294228 @default.
• W2046660201 hasConcept C526584372 @default.
• W2046660201 hasConcept C71924100 @default.
• W2046660201 hasConcept C75088862 @default.
• W2046660201 hasConceptScore W2046660201C126322002 @default.
• W2046660201 hasConceptScore W2046660201C126894567 @default.
• W2046660201 hasConceptScore W2046660201C141071460 @default.
• W2046660201 hasConceptScore W2046660201C2778063415 @default.
• W2046660201 hasConceptScore W2046660201C2779761222 @default.
• W2046660201 hasConceptScore W2046660201C2779978075 @default.
• W2046660201 hasConceptScore W2046660201C2989005 @default.
• W2046660201 hasConceptScore W2046660201C2993294228 @default.
• W2046660201 hasConceptScore W2046660201C526584372 @default.
• W2046660201 hasConceptScore W2046660201C71924100 @default.
• W2046660201 hasConceptScore W2046660201C75088862 @default.
• W2046660201 hasIssue "3" @default.
• W2046660201 hasLocation W20466602011 @default.
• W2046660201 hasLocation W20466602012 @default.
• W2046660201 hasOpenAccess W2046660201 @default.
• W2046660201 hasPrimaryLocation W20466602011 @default.
• W2046660201 hasRelatedWork W113810927 @default.
• W2046660201 hasRelatedWork W1929014698 @default.
• W2046660201 hasRelatedWork W1991335133 @default.
• W2046660201 hasRelatedWork W2004024108 @default.
• W2046660201 hasRelatedWork W2063766855 @default.
• W2046660201 hasRelatedWork W2131816968 @default.
• W2046660201 hasRelatedWork W2361569065 @default.
• W2046660201 hasRelatedWork W2580333266 @default.
• W2046660201 hasRelatedWork W40023729 @default.
• W2046660201 hasRelatedWork W2304521611 @default.
• W2046660201 hasVolume "91" @default.
• W2046660201 isParatext "false" @default.
• W2046660201 isRetracted "false" @default.
• W2046660201 magId "2046660201" @default.
• W2046660201 workType "article" @default.